EGFR is often expressed in basal triple negative breast cancer (TNBC), and is associated with tumor size, poor differentiation, worse relapse-free and overall survival, and shorter metastasis free survival (14, 15). This evidence concerns the gene EGFR and triple-negative breast carcinoma.